A detailed history of Ci Investments Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 117,607 shares of CRL stock, worth $23.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
117,607
Previous 123,786 4.99%
Holding current value
$23.3 Million
Previous $33.5 Million 27.56%
% of portfolio
0.1%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$206.39 - $268.73 $1.28 Million - $1.66 Million
-6,179 Reduced 4.99%
117,607 $24.3 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $513,277 - $689,590
-2,522 Reduced 2.0%
123,786 $33.5 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $29.7 Million - $43.1 Million
-180,379 Reduced 58.82%
126,308 $29.9 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $1.7 Million - $1.91 Million
8,767 Added 2.94%
306,687 $60.1 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $1.47 Million - $1.68 Million
8,013 Added 2.76%
297,920 $62.6 Million
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $41.9 Million - $56.8 Million
218,461 Added 305.77%
289,907 $58.5 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $5.83 Million - $7.39 Million
29,554 Added 70.55%
71,446 $15.6 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $7.52 Million - $10.3 Million
41,236 Added 6285.98%
41,892 $8.24 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $20,413 - $30,239
100 Added 17.99%
656 $140,000
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $140,530 - $199,160
550 Added 9166.67%
556 $158,000
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $486,661 - $621,421
-1,385 Reduced 99.57%
6 $2,000
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $518,342 - $637,495
1,391 New
1,391 $574,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.